HCN News Team – Page 10 – Highly Capitalized

Saturday, October 17, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

UMiami Hands Over Its 1994 Ibogaine Research to Washington

HCN News Team2026-08-21T06:50:27-08:00August 21st, 2026|Psychedelics, US Politics|

LOS ANGELES – The University of Miami has donated its ...

CRB Monitor and NCS Analytics Partner to Bridge the Cannabis Compliance Data Gap

HCN News Team2026-08-21T03:14:05-08:00August 21st, 2026|Business, Compliance|

DENVER – Two of the industry's most data-intensive platforms that ...

Decibel Reports Q2 2026 Financial Results

HCN News Team2026-08-21T02:22:59-08:00August 21st, 2026|Business, Report|

CALGARY – Decibel Cannabis Co. Inc. reported second-quarter net revenue ...

Organigram Pulls Sanity Group Into a Single Global Structure

HCN News Team2026-08-20T08:14:14-08:00August 20th, 2026|Business, Distribution|

TORONTO – Organigram Global Inc. did not wait out the ...

Aurora Takes Ownership of UK Patient Supply Chain with Birmingham Acquisitions

HCN News Team2026-08-20T06:32:32-08:00August 20th, 2026|Business, International, M&As|

EDMONTON – Aurora Cannabis Inc. has acquired two licensed UK ...

Texas’s Dazed Inc Claims Expansion and Buyback Strategy

HCN News Team2026-08-21T04:44:03-08:00August 20th, 2026|Business|

AUSTIN – Dazed Inc., formerly MedX Holdings, Inc., released a ...

Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III

HCN News Team2026-08-19T18:53:20-08:00August 19th, 2026|Business, Insights|

WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement ...

Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split

HCN News Team2026-08-19T02:57:05-08:00August 19th, 2026|Business, Investors|

TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company ...

Johnson & Johnson Signs On to Lead Delix’s $85M Series C

HCN News Team2026-08-19T17:57:26-08:00August 19th, 2026|Business, Psychedelics|

NEW BRUNSWICK – Johnson & Johnson has agreed to lead ...

Analysis: Wall Street Quietly Tests the Water In Cannabis

HCN News Team2026-08-18T16:25:21-08:00August 18th, 2026|Business, Insights|

NEW YORK- For years, institutional investors have largely remained outside ...

Previous 91011 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.